BTIG analyst David Larsen downgrades Signify Health (NYSE:SGFY) from Buy to Neutral.
Cowen & Co. Maintains Outperform on Mobileye Global, Raises Price Target to $42
Cowen & Co. analyst Joshua Buchalter maintains Mobileye Global (NASDAQ:MBLY) with a Outperform and raises the price target from $35 to $42.